ONTARGET Study of Telmisartan, Ramipril, or Both in High-Risk Patients.
Ram
C Venkata S
CV
N Engl J Med. 1992 Sep 3;327(10):669-77
1386652
Circulation. 1999 Sep 7;100(10):1056-64
10477530
Lancet. 2002 Mar 23;359(9311):995-1003
11937178
N Engl J Med. 2003 Nov 13;349(20):1893-906
14610160
N Engl J Med. 2001 Dec 6;345(23):1667-75
11759645
Eur J Heart Fail. 2004 Dec;6(7):937-45
15556056
Eur J Heart Fail. 2008 Feb;10(2):149-56
18279770
N Engl J Med. 2000 Jan 20;342(3):145-53
10639539
Lancet. 2000 Jan 22;355(9200):253-9
10675071
Lancet. 2000 May 6;355(9215):1575-81
10821360
Lancet. 2006 Aug 12;368(9535):581-8
16905022
Lancet. 2001 Sep 29;358(9287):1033-41
11589932
Stroke. 2005 Jun;36(6):1218-26
15879332
Lancet. 2003 Sep 6;362(9386):772-6
13678870
N Engl J Med. 1991 Aug 1;325(5):293-302
2057034
Cerebrovasc Dis. 2007;23(5-6):368-80
17337887
Am Heart J. 2004 Jul;148(1):52-61
15215792
Lancet. 2003 May 31;361(9372):1843-8
12788569
Lancet. 2003 Sep 6;362(9386):767-71
13678869
Lancet. 2003 Sep 6;362(9386):782-8
13678872